Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and Older
Clinical trial NCT00535873 · COMPLETED
Trial details
- NCT number
- NCT00535873
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2013-02-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.